Optimal therapy in genotype 1 patients 3 rd Paris Hepatitis Conference 19-20 January 2009 Stefan Zeuzem, MD J.W. Goethe University Hospital Frankfurt,
Breast Cancer Dr. Padma Poddutoori, PG-Y3, I.M. Dr.Sohail Chaudhry, Attending Physician, Hemoncology.
Multiple Myeloma By Dr Sameh Shamaa. Multiple Myeloma Epidemiology: 1% Of all malignant diseases. Annual incidence: 3-4/100 000. Age: - Median age: 65y.
Percutaneous Treatment of Thoracic Malignancy William Moore, M.D. Associate Professor of Radiology Stony Brook University Medical Center Union University.
Clinical Trials Promotion PAN/NACCDO 2008 Ask About Clinical Trials Campaign Cynthia Manley Associate Director for Communications Vanderbilt-Ingram Cancer.
B.Dahlof (Co-chair), P.Sever (Co-chair), N. Poulter (Secretary) H. Wedel (Statistician), G. Beevers, M. Caulfield, R. Collins S. Kjeldsen, A. Kristinsson,
…when the conditions of an experiment are once established and worked up according to the mind's preconceived idea, an induced or premeditated observation.
HFSA 2010 Comprehensive Heart Failure Practice Guideline Key Recommendations.
Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Adrian F. Hernandez, MD On behalf of the ASCEND-HF Committees, Investigators.
The Role of Antimicrobial Stewardship in the Prevention of Clostridium Difficile Infections Kenneth Lawrence, PharmD Lisa Davidson, MD Tufts Medical Center.
NSTEMI Acute Coronary Syndromes Patrick Hildbrand.
Jean-Marc BOHBOT Institut Fournier PARIS. On estime que, chaque année, 1 milliard de femmes sont atteintes par une infection urinaire ou une infection.